Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1981

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 5
Chunk 1981
---

    Average  
    Per Share 

    Options  
    Exercise
    Price  
    Fair
    Value 
  
    Options outstanding
    at December 31, 2023 
     360,416,665  
    $0.05  
    $0.03 
  
    Granted 
     16,000,000  
    $0.05  
    $0.01 
  
    Canceled/Expired 
     (25,000,000) 
    $0.05  
    $0.03 
  
    Exercised 
     -  
    $-  
    $- 
  
    Options
    outstanding at December 31, 2024 
     351,416,665  
    $0.05  
    $0.03 

Details
of our options outstanding as of December 31, 2024, is as follows:

 SCHEDULE OF OPTIONS OUTSTANDING

    Options
    Exercisable  
    Weighted
    Average Exercise Price of Options Exercisable  
    Weighted
    Average Contractual Life of Options Exercisable (Years)  
    Weighted
    Average Contractual Life of Options Outstanding (Years) 
  
     183,291,665  
     0.05  
     4.48  
     4.62 

    F-19

INVESTVIEW,
INC.

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER
31, 2024 AND 2023

Total
stock compensation expense related to the options for the year ended December 31, 2024 and 2023, was $1,610,536 and $2,555,155, respectively.
As of December 31, 2024 there was approximately $3.3 million of unrecognized compensation cost related to the Options, which is expected
to be recognized over a remaining weighted-average vesting period of approximately 1.2 years.

Warrants

Transactions
involving our warrants are summarized as follows:

 SCHEDULE OF WARRANTS ISSUED

    Weighted 

    Number of  
    Average 

    Shares  
    Exercise
    Price 
  
    Warrants outstanding
    at December 31, 2022 
     1,178,320  
    $0.10 
  
    Granted 
     -